nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimenhydrinate—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.0033	0.0033	CcSEcCtD
Dimenhydrinate—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.0033	0.0033	CcSEcCtD
Dimenhydrinate—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00326	0.00326	CcSEcCtD
Dimenhydrinate—Tension—Alitretinoin—peripheral nervous system neoplasm	0.00322	0.00322	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Etoposide—peripheral nervous system neoplasm	0.00321	0.00321	CcSEcCtD
Dimenhydrinate—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.0032	0.0032	CcSEcCtD
Dimenhydrinate—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.0032	0.0032	CcSEcCtD
Dimenhydrinate—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.0032	0.0032	CcSEcCtD
Dimenhydrinate—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.00319	0.00319	CcSEcCtD
Dimenhydrinate—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00317	0.00317	CcSEcCtD
Dimenhydrinate—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00317	0.00317	CcSEcCtD
Dimenhydrinate—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00314	0.00314	CcSEcCtD
Dimenhydrinate—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00314	0.00314	CcSEcCtD
Dimenhydrinate—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.00314	0.00314	CcSEcCtD
Dimenhydrinate—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.00313	0.00313	CcSEcCtD
Dimenhydrinate—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00311	0.00311	CcSEcCtD
Dimenhydrinate—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00311	0.00311	CcSEcCtD
Dimenhydrinate—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.0031	0.0031	CcSEcCtD
Dimenhydrinate—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00309	0.00309	CcSEcCtD
Dimenhydrinate—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.00308	0.00308	CcSEcCtD
Dimenhydrinate—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00307	0.00307	CcSEcCtD
Dimenhydrinate—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00307	0.00307	CcSEcCtD
Dimenhydrinate—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00307	0.00307	CcSEcCtD
Dimenhydrinate—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00307	0.00307	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00306	0.00306	CcSEcCtD
Dimenhydrinate—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00305	0.00305	CcSEcCtD
Dimenhydrinate—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00305	0.00305	CcSEcCtD
Dimenhydrinate—Constipation—Topotecan—peripheral nervous system neoplasm	0.00305	0.00305	CcSEcCtD
Dimenhydrinate—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00303	0.00303	CcSEcCtD
Dimenhydrinate—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Dimenhydrinate—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Dimenhydrinate—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Dimenhydrinate—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00301	0.00301	CcSEcCtD
Dimenhydrinate—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.003	0.003	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00294	0.00294	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00291	0.00291	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00291	0.00291	CcSEcCtD
Dimenhydrinate—Agitation—Vincristine—peripheral nervous system neoplasm	0.00291	0.00291	CcSEcCtD
Dimenhydrinate—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.0029	0.0029	CcSEcCtD
Dimenhydrinate—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00284	0.00284	CcSEcCtD
Dimenhydrinate—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00284	0.00284	CcSEcCtD
Dimenhydrinate—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00283	0.00283	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00283	0.00283	CcSEcCtD
Dimenhydrinate—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00281	0.00281	CcSEcCtD
Dimenhydrinate—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00281	0.00281	CcSEcCtD
Dimenhydrinate—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00277	0.00277	CcSEcCtD
Dimenhydrinate—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00275	0.00275	CcSEcCtD
Dimenhydrinate—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00274	0.00274	CcSEcCtD
Dimenhydrinate—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00273	0.00273	CcSEcCtD
Dimenhydrinate—Photosensitivity—Epirubicin—peripheral nervous system neoplasm	0.00272	0.00272	CcSEcCtD
Dimenhydrinate—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.0027	0.0027	CcSEcCtD
Dimenhydrinate—Chills—Etoposide—peripheral nervous system neoplasm	0.00264	0.00264	CcSEcCtD
Dimenhydrinate—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00264	0.00264	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00262	0.00262	CcSEcCtD
Dimenhydrinate—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00262	0.00262	CcSEcCtD
Dimenhydrinate—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00261	0.00261	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00259	0.00259	CcSEcCtD
Dimenhydrinate—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00256	0.00256	CcSEcCtD
Dimenhydrinate—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00255	0.00255	CcSEcCtD
Dimenhydrinate—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00254	0.00254	CcSEcCtD
Dimenhydrinate—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00254	0.00254	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00253	0.00253	CcSEcCtD
Dimenhydrinate—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Dimenhydrinate—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Dimenhydrinate—Asthenia—Melphalan—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Dimenhydrinate—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Dimenhydrinate—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00249	0.00249	CcSEcCtD
Dimenhydrinate—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Dimenhydrinate—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Dimenhydrinate—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00242	0.00242	CcSEcCtD
Dimenhydrinate—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00242	0.00242	CcSEcCtD
Dimenhydrinate—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00242	0.00242	CcSEcCtD
Dimenhydrinate—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00242	0.00242	CcSEcCtD
Dimenhydrinate—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Dimenhydrinate—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Dimenhydrinate—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00239	0.00239	CcSEcCtD
Dimenhydrinate—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.00238	0.00238	CcSEcCtD
Dimenhydrinate—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00238	0.00238	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00238	0.00238	CcSEcCtD
Dimenhydrinate—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00236	0.00236	CcSEcCtD
Dimenhydrinate—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00236	0.00236	CcSEcCtD
Dimenhydrinate—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Dimenhydrinate—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Dimenhydrinate—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Dimenhydrinate—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Dimenhydrinate—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Dimenhydrinate—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Dimenhydrinate—Vertigo—Etoposide—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Dimenhydrinate—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00229	0.00229	CcSEcCtD
Dimenhydrinate—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00227	0.00227	CcSEcCtD
Dimenhydrinate—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00225	0.00225	CcSEcCtD
Dimenhydrinate—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00225	0.00225	CcSEcCtD
Dimenhydrinate—Rash—Topotecan—peripheral nervous system neoplasm	0.00225	0.00225	CcSEcCtD
Dimenhydrinate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00224	0.00224	CcSEcCtD
Dimenhydrinate—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00224	0.00224	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Dimenhydrinate—Headache—Topotecan—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Dimenhydrinate—Rash—Tretinoin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Dimenhydrinate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Dimenhydrinate—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Dimenhydrinate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Dimenhydrinate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Dimenhydrinate—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Dimenhydrinate—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00222	0.00222	CcSEcCtD
Dimenhydrinate—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00222	0.00222	CcSEcCtD
Dimenhydrinate—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Dimenhydrinate—Headache—Tretinoin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Dimenhydrinate—Constipation—Vincristine—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Dimenhydrinate—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Dimenhydrinate—Rash—Melphalan—peripheral nervous system neoplasm	0.0022	0.0022	CcSEcCtD
Dimenhydrinate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.0022	0.0022	CcSEcCtD
Dimenhydrinate—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00218	0.00218	CcSEcCtD
Dimenhydrinate—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00213	0.00213	CcSEcCtD
Dimenhydrinate—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00213	0.00213	CcSEcCtD
Dimenhydrinate—Nausea—Topotecan—peripheral nervous system neoplasm	0.00212	0.00212	CcSEcCtD
Dimenhydrinate—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00211	0.00211	CcSEcCtD
Dimenhydrinate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.0021	0.0021	CcSEcCtD
Dimenhydrinate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.0021	0.0021	CcSEcCtD
Dimenhydrinate—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Dimenhydrinate—Nausea—Melphalan—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Dimenhydrinate—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Dimenhydrinate—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00204	0.00204	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00202	0.00202	CcSEcCtD
Dimenhydrinate—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Dimenhydrinate—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00198	0.00198	CcSEcCtD
Dimenhydrinate—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00198	0.00198	CcSEcCtD
Dimenhydrinate—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Dimenhydrinate—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.00193	0.00193	CcSEcCtD
Dimenhydrinate—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Dimenhydrinate—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Dimenhydrinate—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Dimenhydrinate—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00186	0.00186	CcSEcCtD
Dimenhydrinate—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Dimenhydrinate—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Dimenhydrinate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Dimenhydrinate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Dimenhydrinate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Dimenhydrinate—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Dimenhydrinate—Fatigue—Etoposide—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Dimenhydrinate—Constipation—Etoposide—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Dimenhydrinate—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Dimenhydrinate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Dimenhydrinate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Dimenhydrinate—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Dimenhydrinate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Dimenhydrinate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Dimenhydrinate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.0017	0.0017	CcSEcCtD
Dimenhydrinate—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.0017	0.0017	CcSEcCtD
Dimenhydrinate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Dimenhydrinate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Dimenhydrinate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00168	0.00168	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Dimenhydrinate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00166	0.00166	CcSEcCtD
Dimenhydrinate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Dimenhydrinate—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Dimenhydrinate—Rash—Vincristine—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Dimenhydrinate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Dimenhydrinate—Headache—Vincristine—peripheral nervous system neoplasm	0.00162	0.00162	CcSEcCtD
Dimenhydrinate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Dimenhydrinate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Dimenhydrinate—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Dimenhydrinate—Nausea—Vincristine—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Dimenhydrinate—Asthenia—Etoposide—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Dimenhydrinate—Chills—Epirubicin—peripheral nervous system neoplasm	0.00148	0.00148	CcSEcCtD
Dimenhydrinate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Dimenhydrinate—Rash—Cisplatin—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Dimenhydrinate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Dimenhydrinate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00143	0.00143	CcSEcCtD
Dimenhydrinate—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Dimenhydrinate—Tension—Epirubicin—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Dimenhydrinate—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Dimenhydrinate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00138	0.00138	CcSEcCtD
Dimenhydrinate—Chills—Doxorubicin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Dimenhydrinate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Dimenhydrinate—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Dimenhydrinate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Dimenhydrinate—Agitation—Epirubicin—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Dimenhydrinate—Rash—Etoposide—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Dimenhydrinate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Dimenhydrinate—Headache—Etoposide—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Dimenhydrinate—Tension—Doxorubicin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Dimenhydrinate—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Dimenhydrinate—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Dimenhydrinate—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Dimenhydrinate—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Dimenhydrinate—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Dimenhydrinate—Nausea—Etoposide—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Dimenhydrinate—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Dimenhydrinate—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Dimenhydrinate—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Dimenhydrinate—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Dimenhydrinate—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Dimenhydrinate—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Dimenhydrinate—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Dimenhydrinate—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Dimenhydrinate—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Dimenhydrinate—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Dimenhydrinate—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Dimenhydrinate—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Dimenhydrinate—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Dimenhydrinate—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Dimenhydrinate—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Dimenhydrinate—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Dimenhydrinate—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Dimenhydrinate—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Dimenhydrinate—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Dimenhydrinate—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Dimenhydrinate—Constipation—Epirubicin—peripheral nervous system neoplasm	0.001	0.001	CcSEcCtD
Dimenhydrinate—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000981	0.000981	CcSEcCtD
Dimenhydrinate—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000974	0.000974	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000966	0.000966	CcSEcCtD
Dimenhydrinate—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000964	0.000964	CcSEcCtD
Dimenhydrinate—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000955	0.000955	CcSEcCtD
Dimenhydrinate—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000943	0.000943	CcSEcCtD
Dimenhydrinate—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000935	0.000935	CcSEcCtD
Dimenhydrinate—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000931	0.000931	CcSEcCtD
Dimenhydrinate—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000927	0.000927	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000894	0.000894	CcSEcCtD
Dimenhydrinate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000862	0.000862	CcSEcCtD
Dimenhydrinate—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000841	0.000841	CcSEcCtD
Dimenhydrinate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000802	0.000802	CcSEcCtD
Dimenhydrinate—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000778	0.000778	CcSEcCtD
Dimenhydrinate—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000775	0.000775	CcSEcCtD
Dimenhydrinate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000745	0.000745	CcSEcCtD
Dimenhydrinate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000742	0.000742	CcSEcCtD
Dimenhydrinate—Rash—Epirubicin—peripheral nervous system neoplasm	0.000739	0.000739	CcSEcCtD
Dimenhydrinate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000738	0.000738	CcSEcCtD
Dimenhydrinate—Headache—Epirubicin—peripheral nervous system neoplasm	0.000734	0.000734	CcSEcCtD
Dimenhydrinate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000717	0.000717	CcSEcCtD
Dimenhydrinate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000696	0.000696	CcSEcCtD
Dimenhydrinate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00069	0.00069	CcSEcCtD
Dimenhydrinate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000684	0.000684	CcSEcCtD
Dimenhydrinate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000683	0.000683	CcSEcCtD
Dimenhydrinate—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000679	0.000679	CcSEcCtD
Dimenhydrinate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000644	0.000644	CcSEcCtD
